Eur Rev Med Pharmacol Sci 2020; 24 (21): 11421-11427

DOI: 10.26355/eurrev_202011_23635

Is chronic obstructive pulmonary disease an independent predictor for adverse outcomes in coronavirus disease 2019 patients?

W.-W. Xiao, J. Xu, L. Shi, Y.-D. Wang, H.-Y. Yang

Department of Epidemiology, School of Public Health, Zhengzhou University, Zhengzhou, China. yhy@zzu.edu.cn


OBJECTIVE: This study aimed to investigate whether pre-existing chronic obstructive pulmonary disease (COPD) was an independent predictor for adverse outcomes in coronavirus disease 2019 (COVID-19) patients.

MATERIALS AND METHODS: We searched electronic databases, including PubMed, Web of Science, EMBASE, and Chinese National Knowledge Infrastructure (CNKI) to screen for eligible articles. A quantitative meta-analysis was performed on the basis of adjusted effect estimates.

RESULTS: We observed that COPD was significantly associated with an increased risk of adverse outcomes in COVID-19 patients, which is based on 18 studies with 26,075 cases reporting adjusted effect estimates (pooled effect = 1.53, 95% confidence interval (CI): 1.29-1.8; I2 = 35.4%, random-effects model).

CONCLUSIONS: We found that pre-existing COPD was an independent risk factor for predicting the adverse outcomes in COVID-19 patients.

 

 

Free PDF Download

To cite this article

W.-W. Xiao, J. Xu, L. Shi, Y.-D. Wang, H.-Y. Yang
Is chronic obstructive pulmonary disease an independent predictor for adverse outcomes in coronavirus disease 2019 patients?

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 21
Pages: 11421-11427
DOI: 10.26355/eurrev_202011_23635